Abbott Unveils Late-breaking Data Showing the World's First

Abbott Unveils Late-breaking Data Showing the World's First Dual-chamber Leadless Pacemaker Study Met All Three Primary Endpoints

Abbott's AVEIR DR i2i IDE study is the industry's first prospective study on the safety and performance of the world's first dual-chamber leadless pacemaker

Related Keywords

Canada , United States , Amsterdam , Noord Holland , Netherlands , Reinoude Knops , Randel Woodgrift , Amsterdam University Medical Center , Heart Rhythm Society , Drug Administration , Investigational Device Exemption , New Orleans , New England Journal , Breaking Data ,